These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12538024)

  • 1. Relationships between structure, antibacterial activity, serum stability, pharmacokinetics and efficacy in 3-(heteroarylthio)cephems. Discovery of RWJ-333441 (MC-04,546).
    Glinka T; Huie K; Cho A; Ludwikow M; Blais J; Griffith D; Hecker S; Dudley M
    Bioorg Med Chem; 2003 Feb; 11(4):591-600. PubMed ID: 12538024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAR studies of anti-MRSA non-zwitterionic 3-heteroarylthiocephems.
    Glinka TW; Cho A; Zhang ZJ; Ludwikow M; Griffith D; Huie K; Hecker SJ; Dudley MN; Lee VJ; Chamberland S
    J Antibiot (Tokyo); 2000 Oct; 53(10):1045-52. PubMed ID: 11132949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-MRSA cephems. Part 3: additional C-7 acid derivatives.
    Springer DM; Luh BY; Goodrich JT; Bronson JJ
    Bioorg Med Chem; 2003 Jan; 11(2):281-91. PubMed ID: 12470721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-MRSA cephems. Part 2: C-7 cinnamic acid derivatives.
    Springer DM; Luh BY; Goodrich J; Bronson JJ
    Bioorg Med Chem; 2003 Jan; 11(2):265-79. PubMed ID: 12470720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of MC-02,331, a new cephalosporin exhibiting potent activity against methicillin-resistant Staphylococcus aureus.
    Hecker SJ; Cho IS; Glinka TW; Zhang ZJ; Price ME; Lee VJ; Christensen BG; Boggs A; Chamberland S; Malouin F; Parr TR; Annamalai T; Blais J; Bond EL; Case L; Chan C; Crase J; Frith R; Griffith D; Harford L; Liu N; Ludwikow M; Mathias K; Rea D; Williams R
    J Antibiot (Tokyo); 1998 Aug; 51(8):722-34. PubMed ID: 9766464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
    Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA
    Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and structure-activity relationship of a series of 1-carba-1-dethiacephems exhibiting activity against methicillin-resistant Staphylococcus aureus.
    Ternansky RJ; Draheim SE; Pike AJ; Bell FW; West SJ; Jordan CL; Wu CY; Preston DA; Albron W; Kasher JS
    J Med Chem; 1993 Jul; 36(14):1971-6. PubMed ID: 8336336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-MRSA cephems. Part 1: C-3 substituted thiopyridinium derivatives.
    Springer DM; Luh BY; Bronson JJ
    Bioorg Med Chem Lett; 2001 Mar; 11(6):797-801. PubMed ID: 11277523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-3578, a new broad spectrum parenteral cephalosporin exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Synthesis and structure-activity relationships.
    Yoshizawa H; Itani H; Ishikura K; Irie T; Yokoo K; Kubota T; Minami K; Iwaki T; Miwa H; Nishitani Y
    J Antibiot (Tokyo); 2002 Nov; 55(11):975-92. PubMed ID: 12546419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant Staphylococcus aureus.
    Turos E; Long TE; Konaklieva MI; Coates C; Shim JY; Dickey S; Lim DV; Cannons A
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2229-31. PubMed ID: 12127544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series.
    Yoshizawa H; Kubota T; Itani H; Ishitobi H; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4211-9. PubMed ID: 15246097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research and development of new oral cephems, cefixime and cefdinir].
    Sakane K; Kawabata K; Inamoto Y; Yamanaka H; Takaya T
    Yakugaku Zasshi; 1993 Sep; 113(9):605-26. PubMed ID: 8229662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LB11058, a new cephalosporin with high penicillin-binding protein 2a affinity and activity in experimental endocarditis due to homogeneously methicillin-resistant Staphylococcus aureus.
    Vouillamoz J; Entenza JM; Hohl P; Moreillon P
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4322-7. PubMed ID: 15504859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-lactam antibiotic susceptibility testing of MRSA?
    Agrawal G; Jalgaonkar SV
    Indian J Med Microbiol; 2006 Oct; 24(4):304. PubMed ID: 17185859
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo antibacterial activity of RWJ-54428, a new cephalosporin with activity against gram-positive bacteria.
    Griffith DC; Harford L; Williams R; Lee VJ; Dudley MN
    Antimicrob Agents Chemother; 2003 Jan; 47(1):43-7. PubMed ID: 12499167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5,6-Cis-penems: broad-spectrum anti-methicillin-resistant Staphylococcus aureus beta-lactam antibiotics.
    Ishiguro M; Tanaka R; Namikawa K; Nasu T; Inoue H; Nakatsuka T; Oyama Y; Imajo S
    J Med Chem; 1997 Jul; 40(14):2126-32. PubMed ID: 9216830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 3: 7beta-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3'.
    Yoshizawa H; Kubota T; Itani H; Minami K; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4221-31. PubMed ID: 15246098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propenylamide and propenylsulfonamide cephalosporins as a novel class of anti-MRSA beta-lactams.
    Pohlmann J; Vasilevich NI; Glushkov AI; Kellenberger L; Shapiro S; Caspers P; Page MG; Danel F
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4635-8. PubMed ID: 20576430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.